- Filed
- Apr 5, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Dec 31, 2020 | 600.09K sh |
| Shares Diluted restated | FY 2020 · Dec 31, 2019 | 557.34K sh |
| Capex | FY 2020 · Dec 31, 2019 | $0 |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | −$2.37M |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $6.59M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $2.1M |
| Total Assets | FY 2020 · Dec 31, 2019 | $8.14M |
| Eps Diluted restated | FY 2020 · Dec 31, 2019 | −$3.42 |
| Eps Basic restated | FY 2020 · Dec 31, 2019 | −$3.42 |
| Sga Expense | FY 2020 · Dec 31, 2019 | $1.22M |
| Net Income | FY 2020 · Dec 31, 2019 | −$1.91M |
| Revenue | FY 2020 · Dec 31, 2019 | $9.04M |
| Stockholders Equity restated | FY 2020 · Dec 31, 2018 | $10.32M |